Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 23, 1997

View Archived Issues

Hoechst Marion Roussel's product pipeline in review

Novel progestins described by Gedeon Richter

New compounds from Knoll for CNS disorders

Pfizer describes agents for dopamine system disorders

Acetylcholinesterase inhibitors under development at Astra

Abbott searches for squalene synthase inhibitors as hypolipidemics

New SERMs prepared at Lilly

Axokine use in retinal degeneration covered in new patent

BM-41.0904: a potential new osteoanabolic agent

New levobupivacaine clinical data presented at European congress

Genetronics receives Phase I SBIR grant for heparin delivery

Orapex: new dental company formed in Canada

First launch for Zeneca's Seroquel

Celgene's thalidomide approvable for ENL

Geron, Johns Hopkins collaborate on stem cell research

Octreotide acetate clinical study commences for new indication

Clinical trials begin with topical impotence treatment

Orphan Medical licenses out European rights to Antizol

Columbia Laboratories issued U.S. patent for drug delivery technology

Cardizem Monovial approved for U.S. marketing

Amgen seeks partner for inflammation R&D program

Cytoclonal allowed U.S. patent for PKD treatment

Acute vasodilating effects of KDI-792 in diabetics

NABI introduces new formulation of WinRho SDF

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...